Q1 2016 13F Holders as of 31 Mar 2016
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
590,231,680
-
Total 13F shares
-
175,646,398
-
Share change
-
-1,198,313
-
Total reported value
-
$15,492,105,147
-
Put/Call ratio
-
55%
-
Price per share
-
$88.21
-
Number of holders
-
635
-
Value change
-
-$95,187,389
-
Number of buys
-
299
-
Number of sells
-
270
Institutional Holders of Edwards Lifesciences Corp - Common Stock (EW) as of Q1 2016
As of 31 Mar 2016,
Edwards Lifesciences Corp - Common Stock (EW) was held by
635 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
175,646,398 shares.
The largest 10 holders included
VANGUARD GROUP INC, FMR LLC, SANDS CAPITAL MANAGEMENT, LLC, STATE STREET CORP, Capital Research Global Investors, BlackRock Institutional Trust Company, N.A., BlackRock Fund Advisors, FRANKLIN RESOURCES INC, WELLINGTON MANAGEMENT GROUP LLP, and Voya Investment Management LLC.
This page lists
637
institutional shareholders reporting positions in this security
for the Q1 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.